Document is current

Article History

Received: 31 August 2019

Accepted: 20 December 2019

First Online: 9 January 2020

Ethics approval and consent to participate

: The study will be conducted in accordance with Good Clinical Practice (GCP), as defined by the International Conference on Harmonisation (ICH), WHO, and any local directives, and in compliance with the protocol. The study protocol and the patient informed consent has received approval from an Independent Ethics Committee (IEC) of the ethical board of the Kazakh National Medical University in Almaty (application no. 641, IEC session no. 8(72)). The lead researcher will obtain assurance of IEC compliance with regulations. Any changes to the study protocol will be reported to the IEC and disclosed in the trial register.The study will be conducted with personnel who are qualified by education, training and experience to perform their respective tasks.Only patients with signed, dated informed consent are eligible to participate to ensure that subjects are fully informed about the purpose, potential risks and other critical issues regarding the study. The approved informed consent form will adhere to the regional requirements of the IEC and the ethical principles that have their origin in the Declaration of Helsinki. The trial has been registered at . The study findings will be published in scientific papers and presented at conferences in the field of primary health care, implementation science and/or addiction. For all publications, authorship will be based on the criteria of the International Committee of Medical Journal Editors []. This study protocol has been prepared with reference to the SPIRIT guidelines [].

: Not applicable

: The authors declare that they have no competing interests